Editorial: Pathological implications of metabolic and cerebrovascular diseases in neurocognitive disorders

Editorial: Pathological implications of metabolic and cerebrovascular diseases in neurocognitive disorders

Bibliographic Details
Main Authors:	Satoshi Saito, Yoshiki Hase, Masashi Tanaka
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Endocrinology
Subjects:	diabetes mellitus diabetes-associated cognitive dysfunction neurocognitive disorders Alzheimer’s disease small vessel disease vascular cognitive impairment
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1367575/full

Similar Items

A Nomogram Including Total Cerebral Small Vessel Disease Burden Score for Predicting Mild Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
by: Teng Z, et al.
Published: (2024-04-01)

Differentiating Degenerative from Vascular Dementia with the Help of Optical Coherence Tomography Angiography Biomarkers
by: Efthymios Chalkias, et al.
Published: (2022-03-01)

Clinical practice guideline for cognitive impairment of cerebral small vessel disease
by: Dantao Peng, et al.
Published: (2019-06-01)

Major Vascular Neurocognitive Disorder: A Reappraisal to Vascular Dementia
by: Emre Kumral, et al.
Published: (2017-03-01)

Vessel-Associated Immune Cells in Cerebrovascular Diseases: From Perivascular Macrophages to Vessel-Associated Microglia
by: Takashi Koizumi, et al.
Published: (2019-12-01)

Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer’s disease with a comprehensive neuropsychological test
by: Lu Yao, et al.
Published: (2022-06-01)

Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
by: Hanan Ehtewish, et al.
Published: (2022-05-01)

Factors Associated with Changes in Brain Atrophy during a Three-Year Observation in Elderly Diabetic Patients: Effect of Renal Impairment on Hippocampal Atrophy
by: Takahiko Kawamura, et al.
Published: (2016-02-01)

Computerized Neurocognitive Test (CNT) in mild cognitive impairment and Alzheimer's disease
by: Maira Okada de Oliveira, et al.

Neuroimaging Characteristics of Small-Vessel Disease in Older Adults with Normal Cognition, Mild Cognitive Impairment, and Alzheimer Disease
by: Alberto Mimenza-Alvarado, et al.
Published: (2018-05-01)

Editorial: Intramural Vascular Cells: Key Therapeutic Targets for Vascular Cognitive Impairment
by: Satoshi Saito, et al.
Published: (2020-10-01)

A Possible Association Between Executive Dysfunction and Frailty in Patients With Neurocognitive Disorders
by: Massimo Bartoli, et al.
Published: (2020-11-01)

Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus
by: Teng Z, et al.
Published: (2022-07-01)

Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings
by: Lai Gwen Chan, et al.
Published: (2019-04-01)

Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer’s Disease, Cerebral Small Vessel Disease, and Mixed Pathologies
by: Dixon Yang, et al.
Published: (2022-04-01)

Cognitive and emotional impairment in patients with chronic cerebrovascular insufficiency
by: A. B. Bogolepova
Published: (2020-07-01)

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report
by: A. Wallin, et al.
Published: (2017-05-01)

Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study
by: Emilia Salvadori, et al.
Published: (2021-01-01)

A Review on Relationship between Type II Diabetes and Cognitive Impairment
by: Sheida Jamalnia, et al.
Published: (2018-09-01)

Vascular cognitive impairment, no dementia: diagnosis, prognosis, treatment, and prevention
by: A. A. Kulesh, et al.
Published: (2017-11-01)

Lacunes and type 2 diabetes mellitus have a joint effect on cognitive impairment: a retrospective study
by: Hong Zhou, et al.
Published: (2022-03-01)

Long-Term Use of Metformin Is Associated With Reduced Risk of Cognitive Impairment With Alleviation of Cerebral Small Vessel Disease Burden in Patients With Type 2 Diabetes
by: Zhenjie Teng, et al.
Published: (2021-10-01)

Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients
by: Emilia Salvadori, et al.
Published: (2018-03-01)

Decreased integrity of the monoaminergic tract is associated with a positive response to MPH in patients with vascular cognitive impairment - proof of principle study STREAM-VCI
by: Jolene F Leijenaar, et al.
Published: (2022-01-01)

Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis
by: Jia-Hao Zhang, et al.
Published: (2022-08-01)

Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment
by: I. V. Litvinenko, et al.
Published: (2019-06-01)

A multi-disciplinary commentary on preclinical research to investigate vascular contributions to dementia
by: Sarmi Sri, et al.
Published: (2023-01-01)

Cerebral blood flow and cognitive functioning in patients with disorders along the heart–brain axis
by: Anna E. Leeuwis, et al.
Published: (2020-01-01)

Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease
by: Nanae Ishida, et al.
Published: (2021-10-01)

Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort
by: Rachel S. L. Chia, et al.
Published: (2024-01-01)

Epidemiology of neurocognitive disorders in adults from urban-marginalized areas: a door-to-door population-based study in Puente Piedra, Lima, Peru
by: Eder Herrera-Perez, et al.
Published: (2023-10-01)

Exploratory study on the effectiveness of integrative neurocognitive remediation therapy (iNCRT) for cancer survivors
by: A. Rogiers, et al.
Published: (2022-06-01)

Amide proton transfer could be a surrogate imaging marker for predicting vascular cognitive impairment
by: Ronghua Mu, et al.
Published: (2023-11-01)

Pathology and pathogenesis of vascular cognitive impairment – A critical update
by: Kurt A. Jellinger
Published: (2013-04-01)

Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review
by: Lea Daou, et al.
Published: (2023-12-01)

National and international collaborations to advance research into vascular contributions to cognitive decline
by: Danit G Saks, et al.
Published: (2024-01-01)

Interaction between Alzheimer’s Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers
by: Si Eun Kim, et al.
Published: (2022-09-01)

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
by: Maiko T. Uemura, et al.
Published: (2020-04-01)

Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease
by: Philip Benjamin, et al.
Published: (2014-01-01)

Cerebral small vessel disease’s impact on the development of chronic cerebral ischemia: paradigms of treatment
by: E. Yu. Soloveva, et al.
Published: (2020-03-01)